Recombinant Mouse sTNF RI/TNFRSF1A Protein Summary
Product Specifications
Ile22-Ala212, with an N-terminal Met
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
425-R1
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. |
Reconstitution | Reconstitute at 200 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
425-R1/CF
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 200 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: TNF RI/TNFRSF1A
TNF receptor 1 (TNF RI; also called TNF R-p55/p60 and TNFRSF1A) is a 55 kDa type I transmembrane protein member of the TNF receptor superfamily, designated TNFRSF1A (1, 2). Mouse TNF RI is a 454 amino acid (aa) protein that contains a 21 aa signal sequence, a 191 aa extracellular domain (ECD) with a PLAD (pre-ligand assembly domain) that mediates constitutive dimer/trimer formation, followed by four CRD (cysteine-rich domains), a 23 aa transmembrane domain, and a 219 aa cytoplasmic sequence that contains a neutral sphingomyelinase activation domain and a death domain (3, 4). The ECD of mouse TNF RI shares 70%, 88%, 67%, 70% and 64% aa sequence identity with human, rat, canine, feline and porcine TNF RI, respectively. Both TNF RI and TNF RII (TNFRSF1B) are widely expressed and contain four TNF-alpha trimer-binding CRD in their ECD. However, TNF RI is thought to mediate most of the cellular effects of TNF-alpha (3). It is essential for proper development of lymph node germinal centers and Peyer’s patches, and for combating intracellular pathogens such as Listeria (1, 2, 5). TNF RI is also a receptor for TNF-beta /TNFSF1B (lymphotoxin-alpha ) (6). TNF RI is stored in the Golgi and translocates to the cell surface following pro-inflammatory stimuli (7). TNF-alpha stabilizes TNF RI and induces its sequestering in lipid rafts, where it activates NF kappa B and is cleaved by ADAM-17/TACE (8, 9, 16). Release of the 28-34 kDa TNF RI ECD also occurs constitutively and in response to products of pathogens such as LPS, CpG DNA or S. aureus protein A (1, 10-12). Full-length TNF RI may also be released in exosome-like vesicles (13). Release helps to resolve inflammatory reactions, since it down-regulates cell surface TNF RI and provides soluble TNF RI to bind TNF-alpha (10, 14, 15). Exclusion from lipid rafts causes endocytosis of TNF RI complexes and induces apoptosis (1). Mutations of human TNF R1 can result in inflammatory episodes known as TRAPS (TNFR-associated periodic syndrome) (7).
- Pfeffer, K. (2003) Cytokine Growth Factor Rev. 14:185.
- Hehlgans, T. and K. Pfeffer (2005) Immunology 115:1.
- Chan, F.K. et al. (2000) Science 288:2351.
- Lewis, M. et al. (1991) Proc. Natl. Acad. Sci. USA 88:2830.
- Peschon, J.J. et al. (1998) J. Immunol. 160:943.
- Banner, D.W et al. (1993) Cell 73: 431.
- Turner, M.D. et al. (2012) Biosci. Rep. 32:105.
- Legler, D.F. et al. (2003) Immunity 18:655.
- Tellier, E. et al. (2006) Exp. Cell Res. 312:3969.
- Xanthoulea, S. et al. (2004) J. Exp. Med. 200:367.
- Jin, L. et al. (2000) J. Immunol. 165:5153.
- Gomez, M.I. et al. (2006) J. Biol. Chem. 281:20190.
- Islam, A. et al. (2006) J. Biol. Chem. 281:6860.
- Garton, K.J. et al. (2006) J. Leukoc. Biol. 79:1105.
- McDermott, M.F. et al. (1999) Cell 97:133.
Citations for Recombinant Mouse sTNF RI/TNFRSF1A Protein
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
16
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Scavenging Tumor Necrosis Factor alpha Does Not Affect Inhibition of Dentate Granule Cells Following In Vitro Entorhinal Cortex Lesion
Authors: D Kleidonas, A Vlachos
Cells, 2021-11-19;10(11):.
Species: Mouse
Sample Types: Whole Tissue
Applications: Bioassay -
A wake-like state in vitro induced by transmembrane TNF/soluble TNF receptor reverse signaling
Authors: C Dykstra-Ai, KMS Koh, J Nguyen, M Xue, S Roy, JM Krueger
Brain, Behavior, and Immunity, 2021-02-09;0(0):.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Macrophages employ quorum licensing to regulate collective activation
Authors: JJ Muldoon, Y Chuang, N Bagheri, JN Leonard
Nat Commun, 2020-02-13;11(1):878.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Pseudomonas aeruginosa quorum-sensing metabolite induces host immune cell death through cell surface lipid domain dissolution
Authors: D Song, J Meng, J Cheng, Z Fan, P Chen, H Ruan, Z Tu, N Kang, N Li, Y Xu, X Wang, F Shu, L Mu, T Li, W Ren, X Lin, J Zhu, X Fang, MW Amrein, W Wu, LT Yan, J Lü, T Xia, Y Shi
Nat Microbiol, 2018-12-03;0(0):.
Species: Mouse
Sample Types:
Applications: In Vivo -
Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension.
Authors: Goodall L, Ovecka M, Rycroft D, Friel S, Sanderson A, Mistry P, Davies M, Stoop A
PLoS ONE, 2015-09-09;10(9):e0137065.
Applications: Surface Plasmon Resonance -
Generation and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.
Authors: Steeland S, Puimege L, Vandenbroucke R, Van Hauwermeiren F, Haustraete J, Devoogdt N, Hulpiau P, Leroux-Roels G, Laukens D, Meuleman P, De Vos M, Libert C
J Biol Chem, 2014-12-23;290(7):4022-37.
Species: Human
Sample Types: Complex Sample Type
Applications: Enzyme Assay -
Anti-inflammatory cytokines directly inhibit innate but not adaptive CD8+ T cell functions.
Authors: Freeman B, Meyer C, Slifka M
J Virol, 2014-04-16;88(13):7474-84.
Species: Mouse
Sample Types: Whole Cells
Applications: Bioassay -
Glial tumor necrosis factor alpha (TNF-alpha) generates metaplastic inhibition of spinal learning.
Authors: Huie JR, Baumbauer KM, Lee KH, Bresnahan JC, Beattie MS, Ferguson AR, Grau JW
PLoS ONE, 2012-06-20;7(6):e39751.
Species: Rat
Sample Types: In Vivo
Applications: In Vivo -
Cold pre-conditioning neuroprotection depends on TNF-alpha and is enhanced by blockade of interleukin-11.
Authors: Mitchell HM, White DM, Domowicz MS, Kraig RP
J. Neurochem., 2010-12-01;117(2):187-96.
Species: Rat
Sample Types: Whole Tissue
Applications: Bioassay -
Tumor necrosis factor-alpha mediates one component of competitive, experience-dependent plasticity in developing visual cortex.
Authors: Kaneko M, Stellwagen D, Malenka RC, Stryker MP
Neuron, 2008-06-12;58(5):673-80.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
P2Y1 receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-alpha and prostaglandins.
Authors: Domercq M, Brambilla L, Pilati E, Marchaland J, Volterra A, Bezzi P
J. Biol. Chem., 2006-08-01;281(41):30684-96.
Species: Rat
Sample Types: Whole Cells
Applications: Bioassay -
Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.
Authors: Osuchowski MF, Welch K, Siddiqui J, Remick DG
J. Immunol., 2006-08-01;177(3):1967-74.
Applications: ELISA (Standard) -
Sequential ELISA to profile multiple cytokines from small volumes.
Authors: Osuchowski MF, Siddiqui J, Copeland S, Remick DG
J. Immunol. Methods, 2005-07-01;302(1):172-81.
Applications: ELISA (Standard) -
Selective macrophage suppression during sepsis.
Authors: Ellaban E, Bolgos G, Remick D
Cell. Immunol., 2005-02-26;231(1):103-11.
Applications: ELISA (Standard) -
A role for interferon-gamma in focal cerebral ischemia in mice.
Authors: Lambertsen KL, Gregersen R, Meldgaard M, Clausen BH, Heibol EK, Ladeby R, Knudsen J, Frandsen A, Owens T, Finsen B
J. Neuropathol. Exp. Neurol., 2004-09-01;63(9):942-55.
Species: Mouse
Sample Types: In Vivo
Applications: In Vivo -
Thyrocytes isolated from autoimmune-diseased thyroids secrete soluble tumor necrosis factor-R1 that is related to their elevated protein kinase C activity.
Authors: LaBue M, Colburn KK, Green LM
Thyroid, 2004-04-01;14(4):249-62.
Applications: ELISA (Standard)
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Mouse sTNF RI/TNFRSF1A Protein
There are currently no reviews for this product. Be the first to review Recombinant Mouse sTNF RI/TNFRSF1A Protein and earn rewards!
Have you used Recombinant Mouse sTNF RI/TNFRSF1A Protein?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image